Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    14627786 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis
Conditions: Psoriasis;   Vascular Inflammation;   Coronary Atherosclerosis
Interventions: Biological: adalimumab;   Device: UVB Phototherapy;   Other: Topical treatment
To Top

† Indicates status has not been verified in more than two years